PERTH, Australia, Jan. 7, 2025 /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation...
Hence then, the article about argent biopharma ltd raised us 4 500 000 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Argent BioPharma Ltd. Raised US$4,500,000 )
Also on site :
- 2010s Rock Band Announces Tour for 10th Anniversary of Debut Album
- The Best 5 One Chicago Couples Of All Time
- Nuclear neighbors and a two‑front threat: Why India needs a rocket force